Researchers evaluated the safety of SER-109 and its effect on CDI recurrence among adult outpatients.
All articles by Dee Rapposelli
Researchers evaluated health-related quality life outcomes among patients with a history of recurrent CDI who received either SER-109 or placebo.
Researchers evaluated the use of perioperative vancomycin powder for protection against periprosthetic joint infections following total knee replacement
Latest News Your top articles for WednesdayFor More Personalized News
Haymarket Medical NetworkTop Picks
Continuing Medical Education (CME/CE) Courses